Alloy Therapeutics vs Network Bio
Alloy Therapeutics vs Network Bio, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alloy Therapeutics is on 51/100 and Network Bio on 60/100.
Where each one leads
Alloy Therapeutics
- agent readiness: 39/100 against 21/100
- funding raised: $157M against $100M
Network Bio
- our overall score: 60/100 against 51/100
At a glance
| Measure | Alloy Therapeutics | Network Bio |
|---|---|---|
| What it is | A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services. | Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine. |
| Category | Biotechnology, Artificial Intelligence, Drug Discovery, Drug Development | Biotechnology, Artificial Intelligence, Drug Discovery, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2023 |
| Headquarters | Boston, USA | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alloy Therapeutics | Network Bio |
|---|---|---|
| Employees | Not published | 24 |
| Total funding | $157M | $100M |
| Latest round | Series E | Seed |
| Valuation | $1.0B | $1.1B |
| LinkedIn followers | Not published | 1,519 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alloy Therapeutics | Network Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 60/100 |
| Traction | 40/100 | 54/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 15/100 | 22/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 47/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alloy Therapeutics | Network Bio |
|---|---|---|
| Hosting | Not detected | Linode |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
Alloy Therapeutics vs Network Bio: common questions
Which is better, Alloy Therapeutics or Network Bio?
On our 0-100 score Network Bio rates higher (60/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Alloy Therapeutics and Network Bio compare on the numbers?
Alloy Therapeutics leads on agent readiness (39/100 against 21/100), funding raised ($157M against $100M). Network Bio leads on our overall score (60/100 against 51/100).
Read the full Alloy Therapeutics review and pricing or the Network Bio review and pricing. You can also browse other Alloy Therapeutics alternatives we track.